IL-17 Genetic and Immunophenotypic Evaluation in Chronic Graft-versus-Host Disease
Table 4
Clinical characteristics of recipients with cGVHD (), recipients without cGVHD (), and healthy individuals () included in the immunophenotypic analysis.
Groups
Age median
Individuals gender
Donor gender
Source of cells
Media time after HSCT
With cGVHD
8
37.2
Female = 2 (25%)
Female = 1 (12.5%)
BMSC = 2 (25%)
5 years and 8 months
Male = 6 (75%)
Male = 7 (87.5%)
PBSC = 6 (75%)
Without cGVHD
4
41.5
Female = 3 (75%)
Female = 2 (50%)
BMSC = 4 (100%)
6 years and 1 month
Male = 1 (25%)
Male = 2 (50%)
PBSC = 0
Healthy individuals
3
26.6
Female = 2 (66.7%)
—
—
—
Male = 1 (33.3%)
BMSC: bone marrow stem cells; PBSC: peripheral blood stem cells.
